Sohini Kulavi

Virtual Screening through Molecular Docking Analysis to Identify Potential Natural Inhibitor(s) of Lyn Tyrosine Kinase- An In-silico Approach

Sohini Kulavi, Soham Banerjee, Titav Sengupta, Chandreyi Ghosh, Moumita Saha & Sirshendu Chatterjee · Journal of Pharmaceutical Research International · 2021

Breast cancer on becoming one of the leading cancer types, emerged as an important barrier in increasing life expectancy of the overall population. In the current study, some compounds were screened based on literature survey for the identification of natural bioactive compounds...

Open access Research Article 10.9734/jpri/2021/v33i50A33385

One Size Does Not Fit All: An Overview of Personalized Treatment in Cancer

Sohini Kulavi, Chandreyi Ghosh, Moumita Saha & Sirshendu Chatterjee · Journal of Pharmaceutical Research International · 2021

The last few decades have witnessed 'one size fits all' kind of conventional treatment strategy i.e. a similar line of treatment or usage of the same drug to treat a particular disease. This approach is not associated with specific personal characteristics but with individual gen...

Open access Research Article 10.9734/jpri/2021/v33i28A31513

Breast Cancer: Classification, Risk Factors, Current Diagnostic Procedures and Therapeutics

Chandreyi Ghosh, Sohini Kulavi, Moumita Saha & Sirshendu Chatterjee · Journal of Cancer and Tumor International · 2023

The aetiology of breast cancer is complicated. In population health, breast cancer significantly impacts the most typical invasive malignancy and the second most typical death source for women. The most crucial point for the best prognosis is identifying early-stage cancer cells....

Open access Research Article 10.9734/jcti/2023/v13i3235